The Symptomatic Effect of Cisapride in Patients with Irritable Bowel Syndrome and Constipation

References

• Camilleri M, Choi MG. Irritable bowel syndrom. Aliment Pharmacol Ther 1997;11:3–15.
   PubMed Web of Science ®Google Scholar
• Müller-Lissner SA, the Bavarian Constipation Study Group. Treatment of chronic constipation with cisapride and placebo. Gut 1987;28:1033–8.
   Google Scholar
• Müller-Lissner SA, the Bavarian Constipation Study Group. Cisapride in chronic idiopathic constipation: can the colon be reeducated? Eur J Gastroenterol Hepatol 1995;7:69–73.
   Google Scholar
• Wiseman LR, Faulds D. Cisapride: an updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 1994;47:116–52.
   PubMed Web of Science ®Google Scholar
• Verheyen K, Vervaeke M, DeMyttenaere P, van Mierlo FJ. Double-blind comparison of two cisapride dosage regimens with placebo in the treatment of functional constipation. A general-practice multicenter study. Curr Ther Res 1987;41:978–85.
   Google Scholar
• Bazzocchi G, Ellis J, Villanueva-Meyer J, Jing J, Reddy SN, Mena I, et al. Postprandial colonic transit and motor activity in chronic constipation. Gastroenterology 1990;98:686–93.
   Google Scholar
• Weber FH, McCallum RW. Clinical approaches to irritable bowel syndrome. Lancet 1992;340:1447–52.
   PubMedGoogle Scholar
• Lynn RB, Friedman LS. Irritable bowel syndrome. N Engl J Med 1993;329:1940–5.
   PubMed Web of Science ®Google Scholar
• Van Outryve M, Milo R, Toussaint J, Van Eeghem P. ‘Prokinetic’ treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride. J Clin Gastroenterol 1991;13:49–57.
   Google Scholar
• Schütze K, Brandstätter G, Dragosics B, Judmaier G, Hentschel E. Double-blind study of the effect of cisapride on constipation and abdominal discomfort as component of the irritabe bowel syndrome. Aliment Pharmacol Ther 1997;11:387–94.
   PubMed Web of Science ®Google Scholar
• Thompson WG, Dotevall G, Drossman DA, Heaton KW, Kruis W. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterol Int 1989;2:92–5.
   Google Scholar
• Altman DG, Gardner MJ. Calculating confidence intervals for means and their differences. In: Gardner MJ, Altman DG, editors. Statistics with confidence—confidence intervals and statistical guidelines. London: British Medical Journal; 1990. p. 20–7.
   Google Scholar
• Gardner MJ, Altman DG. Calculating confidence intervals for proportions and their differences. In: Gardner MJ, Altman DG, eds. Statistics with confidence—Confidence intervals and statistical guidelines. London: British Medical Journal; 1990. p. 28–33.
   Google Scholar
• Krevsky B, Malmud LS, Maurer AH, Somers MB, Siegel JA, Fisher RS. The effect of oral cisapride on colonic transit. Aliment Pharmacol Ther 1987;1:293–304.
   PubMedGoogle Scholar
• Stivland T, Camilleri M, Vassallo M, Proano M, Rath D, Brown M, et al. Scintigrafic measurement of regional gut transit in idiopathic constipation. Gastroenterology 1991;101:107–15.
   PubMed Web of Science ®Google Scholar
• Krevsky B, Maurer AH, Malmud LS, Fisher RS. Cisapride accelerates colonic transit in constipated patients with colonic inertia. Am J Gastroenterol 1989;84:882–7.
   PubMed Web of Science ®Google Scholar
• Madsen JL. Effects of cisapride on gastrointestinal transit in healthy humans. Dig Dis Sci 1990;35:1500–4.
   PubMedGoogle Scholar
• Connell AM. The motility of the pelvic colon. Paradoxical motility in diarrhoea and constipation. Gut 1967;3:342–8.
   Google Scholar
• Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al. U.S. householder survey of functional gastrointestinal disorderes. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569–80.
   Google Scholar
• Jones R, Lydeard S. Irritable bowel syndrom in the general population. Br Med J 1992;304:87–90.
   PubMed Web of Science ®Google Scholar
• Arvanitakis C, Nikopoulos A, Theoharidis A, Giannoulis E, Vagios I, Anthopoulou H, et al. Cisapride and ranitidine in the treatment of gastro-oesophageal reflux disease—a comparative randomized double-blind trial. Aliment Pharmacol Ther 1993; 7:635–41.
   PubMedGoogle Scholar
• Tytgat GNJ, Anker Hansen OJ, Carling L, de Groot GH, Geldof H, Glise H, et al. Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug. Scand J Gastroenterol 1992;27:175–83.
   PubMed Web of Science ®Google Scholar
• Toussaint J, Gossuin A, Deruyttere M, Huble F, Devis G. Healing and prevention of relapse of reflux oesophagitis by cisapride. Gut 1991;32:1280–5.
   PubMed Web of Science ®Google Scholar